Our stellar results reflect the power of innovation and the growing impact of our expanding portfolio, particularly in our AtriClip platform and cryoSPHERE device offerings.
10–20% of CABG patients have Afib, yet CABG has the lowest rate of surgical ablation—leaving many patients undertreated.
The impact?
Increased stroke risk and reduced long-term survival.
10–20% of CABG patients have Afib, yet CABG has the lowest rate of surgical ablation—leaving many patients undertreated.
The impact?
Increased stroke risk and reduced long-term survival.
Today’s technology allows surgical ablation to be added quickly and efficiently, without significant time or complexity—making screening and treatment in the OR essential.
Learn more about surgical solutions: <a href="https://okt.to/5Q1AyZ" target="_blank">https://okt.to/5Q1AyZ</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=CABG&highlightedUpdateU…; target='_blank'>#CABG</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=SurgicalAblation&highli…; target='_blank'>#SurgicalAblation</a>
Join us for an upcoming workshop designed for advanced practice providers, PAs, RNs and NPs to explore patient selection, procedural techniques, care team collaboration, and more.
Register at: <a href="https://t.co/ezXgANn9k2" target="_blank">https://t.co/ezXgANn9k2</a>
<a href="https://twitter.com/hashtag/MedEd?src=hashtag_click" target="_blank">#MedEd</a> <a href="https://twitter.com/hashtag/Afib?src=hashtag_click" target="_blank">#Afib</a>
A multidisciplinary approach matters.
Join us for an upcoming workshop September 30-October 1 designed for advanced practice providers, PAs, RNs and NPs to explore patient selection, procedural techniques, care team collaboration, and more.
Hear why a heart team approach makes all the difference.
Register at: <a href="https://okt.to/dTQc6X" target="_blank">https://okt.to/dTQc6X</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=MedEd&highlightedUpdate…; target='_blank'>#MedEd</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a>
As a sales professional at AtriCure, you will play a vital role in transforming patient care by educating and consulting with cardiac surgeons and electrophysiologists about our cutting-edge surgical solutions.
Your impact goes beyond sales, as you collaborate to develop programs, pioneer first-of-their-kind procedures, and enhance patient care pathways.
If you're seeking a career that combines professional growth with a deep commitment to improving patient lives, explore our opportunities available nationwide: <a href="https://okt.to/LOgX07" target="_blank">https://okt.to/LOgX07</a>
Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.
Learn more about transitional pain: <a href="https://t.co/rbGp7fDgpa" target="_blank">https://t.co/rbGp7fDgpa</a>
Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery at home, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.
Learn more about transitional pain: <a href="https://bit.ly/3T0oKZ2" target="_blank">https://bit.ly/3T0oKZ2</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>
Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery at home, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.
Learn more about transitional pain: <a href="https://okt.to/jXbnRi" target="_blank">https://okt.to/jXbnRi</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>
Individuals with symptomatic IST typically have heart rates greater than 100 bpm even with minimal activity. For those who don’t respond to medications, the HEAL-IST clinical trial is evaluating a new hybrid ablation procedure as a potential treatment. Learn more:
